Treace Medical Concepts, Inc. Increase (Decrease) in Accrued Liabilities
Treace Medical Concepts, Inc. (TMCI) reported Increase (Decrease) in Accrued Liabilities of -$372.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-07
- Treace Medical Concepts, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $2.75M, a 221.35% increase year-over-year.
- Treace Medical Concepts, Inc. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$3.13M.
- Treace Medical Concepts, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-12-31 was $778.00K, a 83.96% decline year-over-year.
- Treace Medical Concepts, Inc. increase (decrease) in accrued liabilities for the quarter ending 2025-09-30 was $2.12M.
- Treace Medical Concepts, Inc. increase (decrease) in accrued liabilities for fiscal 2025 was -$2.41M.
- Treace Medical Concepts, Inc. increase (decrease) in accrued liabilities for fiscal 2024 was -$7.90M, a 204.98% decline from fiscal 2023.
- Treace Medical Concepts, Inc. increase (decrease) in accrued liabilities for fiscal 2023 was $7.53M, a 5.66% increase from fiscal 2022.
- Treace Medical Concepts, Inc. increase (decrease) in accrued liabilities for fiscal 2022 was $7.13M, a 7.79% increase from fiscal 2021.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month | Increase (Decrease) in Accrued Liabilities 9 month | Increase (Decrease) in Accrued Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$372.00K 10-Q · filed 2026-08-07 | $406.00K derived: sum of 3 quarters · filed 2026-08-07 | $2.52M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | -$3.13M 10-Q · filed 2026-05-08 | -$2.35M derived: sum of 2 quarters · filed 2026-05-08 | -$230.00K derived: sum of 3 quarters · filed 2026-05-08 | $627.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $778.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $2.90M derived: sum of 2 quarters · filed 2026-02-27 | $3.75M derived: sum of 3 quarters · filed 2026-08-07 | -$2.41M 10-K · filed 2026-02-27 |
| 2025-09-30 | $2.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $2.98M derived: sum of 2 quarters · filed 2026-08-07 | -$3.19M 10-Q · filed 2025-11-06 | $1.66M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $857.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | -$5.31M 10-Q · filed 2026-08-07 | -$459.00K derived: sum of 3 quarters · filed 2026-08-07 | -$7.27M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | -$6.17M 10-Q · filed 2026-05-08 | -$1.32M derived: sum of 2 quarters · filed 2026-05-08 | -$8.13M derived: sum of 3 quarters · filed 2026-05-08 | -$7.15M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $4.85M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$1.96M derived: sum of 2 quarters · filed 2026-02-27 | -$985.00K derived: sum of 3 quarters · filed 2026-02-27 | -$7.90M 10-K · filed 2026-02-27 |
| 2024-09-30 | -$6.81M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$5.83M derived: sum of 2 quarters · filed 2025-11-06 | -$12.75M 10-Q · filed 2025-11-06 | -$3.27M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $975.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$5.94M 10-Q · filed 2025-08-07 | $3.54M derived: sum of 3 quarters · filed 2026-02-27 | $4.72M derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$6.92M 10-Q · filed 2025-05-08 | $2.56M derived: sum of 2 quarters · filed 2026-02-27 | $3.75M derived: sum of 3 quarters · filed 2026-02-27 | $4.69M derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $9.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $10.66M derived: sum of 2 quarters · filed 2026-02-27 | $11.60M derived: sum of 3 quarters · filed 2026-02-27 | $7.53M 10-K · filed 2026-02-27 |
| 2023-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-05 | $2.12M derived: sum of 2 quarters · filed 2024-11-05 | -$1.95M 10-Q · filed 2024-11-05 | $4.95M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $939.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | -$3.14M 10-Q · filed 2024-08-06 | $3.77M derived: sum of 3 quarters · filed 2025-02-27 | $4.95M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$4.08M 10-Q · filed 2024-05-07 | $2.83M derived: sum of 2 quarters · filed 2025-02-27 | $4.01M derived: sum of 3 quarters · filed 2025-02-27 | $5.67M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $6.90M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $8.08M derived: sum of 2 quarters · filed 2025-02-27 | $9.74M derived: sum of 3 quarters · filed 2025-02-27 | $7.13M 10-K · filed 2025-02-27 |
| 2022-09-30 | $1.18M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $2.84M derived: sum of 2 quarters · filed 2023-11-09 | $222.00K 10-Q · filed 2023-11-09 | $6.09M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $1.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$958.00K 10-Q · filed 2023-08-09 | $4.92M derived: sum of 3 quarters · filed 2024-02-27 | $6.25M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | -$2.62M 10-Q · filed 2023-05-09 | $3.25M derived: sum of 2 quarters · filed 2024-02-27 | $4.59M derived: sum of 3 quarters · filed 2024-02-27 | $5.16M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $5.87M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $7.21M derived: sum of 2 quarters · filed 2024-02-27 | $7.78M derived: sum of 3 quarters · filed 2024-02-27 | $6.61M 10-K · filed 2024-02-27 |
| 2021-09-30 | $1.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $1.90M derived: sum of 2 quarters · filed 2022-11-09 | $737.00K 10-Q · filed 2022-11-09 | $3.75M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-06-30 | $567.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-10 | -$600.00K 10-Q · filed 2022-08-10 | $2.41M derived: sum of 3 quarters · filed 2023-03-08 | $3.78M derived: sum of 4 quarters · filed 2023-03-08 |
| 2021-03-31 | -$1.17M 10-Q · filed 2022-05-06 | $1.84M derived: sum of 2 quarters · filed 2023-03-08 | $3.21M derived: sum of 3 quarters · filed 2023-03-08 | $4.03M derived: sum of 4 quarters · filed 2023-03-08 |
| 2020-12-31 | $3.01M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-08 | $4.38M derived: sum of 2 quarters · filed 2023-03-08 | $5.19M derived: sum of 3 quarters · filed 2023-03-08 | $1.14M 10-K · filed 2023-03-08 |
| 2020-09-30 | $1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $2.18M derived: sum of 2 quarters · filed 2021-11-04 | -$1.87M 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $818.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | -$3.23M 10-Q · filed 2021-08-05 | ||
| 2020-03-31 | -$4.05M 10-Q · filed 2021-05-25 | |||
| 2019-12-31 | $3.86M 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |